RXST Live signals | Maximize Profits with Getagraph.com

BUY 101244 min ago

@ $51.45

Issued: 14 Feb 2024 @ 11:15

Return: 2.70%

Previous signal: Feb 14 - 09:33

Previous signal: Sell

Return: -0.56 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Stats
Today's Volume	281 302
Average Volume	401 125
Market Cap	1.95B
EPS	$0 ( 2024-02-28 )
Next earnings date	( $-0.170 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-37.48
ATR14	$0.0790 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Thunen Shelley B	Sell	8 857	Common Stock
2024-04-01	Thunen Shelley B	Sell	800	Common Stock
2024-04-01	Thunen Shelley B	Sell	8 938	Common Stock
2024-04-01	Thunen Shelley B	Sell	662	Common Stock
2024-04-01	Thunen Shelley B	Sell	200	Common Stock

INSIDER POWER
5.76
Last 100 transactions
Buy: 649 170 \| Sell: 601 875

Volume Correlation

Long: -0.40 (neutral)

Short: 0.86 (strong)

Signal:(43.195) Same movement expected

RxSight, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations
FEYE	-0.827
SVAC	-0.804

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

RxSight, Inc. Correlation - Currency/Commodity

0.37
( neutral )

0.11
( neutral )

0.00
( neutral )

-0.46
( neutral )

0.51
( weak )

-0.11
( neutral )

RxSight, Inc. Financials

Annual	2023
Revenue:	$89.08M
Gross Profit:	$53.77M (60.36 %)
EPS:	$-1.410

Q4	2023
Revenue:	$28.58M
Gross Profit:	$17.65M (61.77 %)
EPS:	$-0.260

Q3	2023
Revenue:	$30.67M
Gross Profit:	$13.73M (44.77 %)
EPS:	$-0.350

Q2	2023
Revenue:	$20.81M
Gross Profit:	$12.02M (57.74 %)
EPS:	$-0.400

Financial Reports:

No articles found.

RxSight, Inc.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.